[Effect of epidermal growth factor (EGF) on mouse sperm capacitation]. 1993

S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
Department of Obstetrics and Gynecology, Nerima General Hospital, Tokyo.

The effect of epidermal growth factor (EGF) on the kinetics of mouse sperm capacitation was examined. The chlortetracycline (CTC) fluorescence assay was used to monitor capacitated sperm, featuring a B pattern. One hundred ng/ml EGF significantly stimulated capacitation at 15 minutes after the addition. However, 0.1 pg/ml EGF did not stimulate capacitation. EGF affected neither the motility nor the appearance of the S or AR pattern. The EGF-induced stimulation of capacitation was attenuated by 20 micrograms/ml genistein, an inhibitor of protein tyrosine kinase, or by 100 ng/ml thapsigargin, a non-phorbol tumor promoter, which inhibits EGF action by enhancing phosphorylation of the threonine 669 residue of the EGF-receptor. However, 3 ng/ml 12-O-tetradecanoly phorbol 13-acetate (TPA), a stimulator of protein kinase C, did not attenuate the appearance of the B pattern enhanced by 100 ng/ml EGF. These data suggest that EGF stimulates mouse sperm capacitation by activating the tyrosine kinase of the EGF-receptor which is regulated by multisite phosphorylation.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013075 Sperm Capacitation The structural and functional changes by which SPERMATOZOA become capable of oocyte FERTILIZATION. It normally requires exposing the sperm to the female genital tract for a period of time to bring about increased SPERM MOTILITY and the ACROSOME REACTION before fertilization in the FALLOPIAN TUBES can take place. Capacitation of Spermatozoa,Capacitation, Sperm,Spermatozoa Capacitation
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
January 1990, Uspekhi fiziologicheskikh nauk,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
March 1996, Bailliere's clinical gastroenterology,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
September 1986, The Journal of surgical research,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
January 2023, Reproduction, fertility, and development,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
May 1983, Cancer,
S Furuya, and Y Endo, and M Oba, and T Ito, and S Suzuki, and S Nozawa
April 1986, The Journal of biological chemistry,
Copied contents to your clipboard!